Following the knockdown of ZFHX4-AS1 and the overexpression of ZFHX4-AS1, there were substantial changes in the expression of ZFHX4 in glioma cells as determined by RT-PCR (Figure 7A) and Western Blot (Figure 7B) analysis. The gene discussed is ZFHX4; the disease is central nervous system cancer.